TheFortuneFinancial.com Initializes Free Analyst Research on NKTR, DPTR, NCMI and INSM
15 Mai 2009 - 3:49PM
Marketwired
TheFortuneFinancial.com provides the highest level of independent
research and investment strategies with the sole purpose of
consistently identifying stocks that provide the biggest return on
investment for our subscribers. Investors seeking free and unbiased
analyst opinions on the companies mentioned in this release are
encouraged to register at
http://www.thefortunefinancial.com/index.php?id=78 for a free
subscription to access these reports.
Today, we have asked some of the top analysts worldwide to give
us their updated feedback regarding the current market activity and
position on Nektar Therapeutics (NASDAQ: NKTR), Delta Petroleum
Corporation (NASDAQ: DPTR), National CineMedia Inc. (NASDAQ: NCMI)
and Insmed Incorporated (NASDAQ: INSM).
To have free access to these analyst opinions, sign up now to
www.thefortunefinancial.com by clicking the link below. We have
other reports that could be of interest to you and they are free of
charge with no strings attached.
http://www.thefortunefinancial.com/index.php?id=78
All analyst reviews will be posted for free under "today's
articles" within 24 hours they are advertized online.
Each interview will vary and may include, but will not be
limited to the following:
-- An Unbiased View of the Company
-- Short-term Target Prices
-- Long-term Resistance and Support Levels
-- Analyst Opinions
-- Sector Review
-- Competition Overview
Investors looking to access these analytical opinions and
reports are encouraged to sign up now at
http://www.thefortunefinancial.com/index.php?id=78
Being a member with www.thefortunefinancial.com gives the unique
opportunity to receive a free "custom stock review" on any large
cap equity you currently hold in your portfolio. Simply sign up for
your free membership today, and in the members section of
www.thefortunefinancial.com, you can submit your stock review to an
analyst for his or her opinion of any stocks you currently
following by filling out the form under the tab "request a stock
review."
TheFortuneFinancial.com is not affiliated or compensated by any
of the above mentioned companies, nor do we own a position in any
of the companies.
NASDAQ:NCMI NASDAQ:INSM NASDAQ:NKTR NASDAQ:DPTR
Insmed (NASDAQ:INSM)
Graphique Historique de l'Action
De Août 2024 à Sept 2024
Insmed (NASDAQ:INSM)
Graphique Historique de l'Action
De Sept 2023 à Sept 2024